A qualitative study exploring community pharmacists’ views regarding their role in CVD risk management and prevention in Alexandria, Egypt
- At: 2012 FIP Congress in Amsterdam (the Netherlands)
- Type: Poster
- By: AL-SAEED, Eman (University of Cambridge, Institute of Public Health, The Primary Care Unit, Cambridge, United Kingdom)
- Co-author(s): El-Khordagui, L. (Faculty of Pharmacy, Alexandria University, Alexandria, Egypt)
Mant, J. (University of Cambridge, Institute of Public Health, Cambridge, United Kingdom)
BackgroundCardiovascular diseases (CVD) are the leading cause of preventable deaths in Egypt. Worldwide, there is evidence that community pharmacists (CP) can facilitate change in health behaviour. Today, there are approximately 160,000 registered pharmacists across Egypt; but data relating to their role is lacking.AimThis study explores CPs’.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.